Transmissible spongiform encephalopathies (TSEs or priori diseases) such as Creutzfeldt-Jakob disease and kuru in man or scrapie in sheep presented and still present major challenges to biomedical research. The first phase of investigation of these diseases was dominated by experiments at the biological level and led to the discovery of transmissibility, the existence of strains, as well as the peculiar properties of the transmissible agent, such as lack of immunogenicity and very long incubation times. The unusual resistance to radiation led to the proposal that the agent, or prion, might be devoid of nucleic acid (in this paper we will use the term prion to signify infectious TSE agent, regardless of its composition or structure). The next phase, in which we and our colleagues at the Institute of Molecular Biology of Z0rich University participated, initially in collaboration with Stan Prusiner and his colleagues, saw the isolation and biochemical characterization of PrP s~ and PrP c (Oesch et al., 1985) , followed by the cloning of the PrP gene (Basler et al., 1986) , and the establishment of genetic linkage between it and familial prion disease (Hsiao et al., 1989) . In the third phase, transgenic experimentation strengthened the link between the PrP gene and susceptibility to prion disease by showing that the socalled species barrier could be overcome, at least in some cases, by introducing the PrP gene of the donor into the recipient (Prusiner et al., 1990) . It also became clear that mice expressing PrP transgenes with particular mutations acquired neurodegenerative diseases; however, with a possible exception (Telling et al., 1996) , these were not transmissible.
Since the mid 1960s, the nature of the transmissible agent has being continuously debated. Inasmuch as a virus is understood to consist of a protein-encased nucleic acid encoding some or all of its constituent proteins, the concept of a "slow" or "unconventional" virus lost support as intense efforts in many laboratories failed to identify a TSE-specific nucleic acid or even a nucleic acid long enough to encode a small protein (Riesner et al., 1993) . Nonetheless, a valiant rear guard still clings to the idea that a virus, perhaps an endogenous virus whose nucleic acid would not score as extraneous, is responsible for TSEs (Chesebro, 1999; Manuelidis, 2003) . The virino hypothesis, which holds that the infectious agent consisted of an agent-specific nucleic acid *Correspondence: chades.weissmann@prion.ucl.ac.uk enveloped in a host-specified protein, was proposed to explain the lack of an immune response by the host as well as strain variation (Kimberlin, 1982) . On the other hand, the biochemical linkage of the infectious agent and PrP s~, a protease-resistant, aggregated conformational isomer of the normal host protein PrP c (Gabizon et al., 1988) , and the linkage between the PrP gene, prion diseases, and susceptibility to prions provided support for an updated version of the "protein only" hypothesis (Griffith, 1967) , namely, that the infectious agent is PrP sc that "multiplies" by catalyzing the conversion of PrP c into a likeness of itself (Prusiner, 1991) . A further proposal (Weissmann, 1991) attempted to mediate between the two camps by suggesting that the conversion of PrP c to an abnormal conformer is indeed an essential pathogenic event, but that a small hostspecified nucleic acid associated with PrP s~, the "coprion," is a critical component required to modulate strain specificity. However, this "unified theory" only succeeded in unifying the two camps against itself.
Toward the end of the 1980s, work by O. Smithies, M. Capecchi, M. L. Hooper, D. M. Melton, and A. Bradley had made it clear that gene knockout in the mouse was a feasible undertaking, so that we decided in 1988 to try and generate a PrP knockout mouse and tackle the basic question of whether PrP was essential for susceptibility to TSEs and propagation of prions. Michel Aguet, who had recently joined us as Associate Professor, undertook to acquire the necessary mouse technology, mostly from Horst Bluethmann at Hoffmann-LaRoche, and in 1989 one of us (H.B.), a first-year graduate student, started attempts to target the PrP gene in embryonal stem (ES) cells that had been donated by Rolf Kemler and Allan Bradley, along with much good advice. After several failed attempts, we finally concentrated our efforts on a deletion vector in which two thirds of the PrP coding region had been replaced by a neomycin resistance gene. Because at the time no counterselection against ectopic insertion of the deletion vector was used, some 10,000 ES cell clones had to be screened until a single clone heterozygous for the targeting event was found. After implantation of more than thousand blastocysts injected with cells from this single clone, over a period of some 6 months, germline transmission by a chimeric offspring, derived from Bradley's AB1 ES cells, was finally achieved and resulted in a mouse heterozygous for the PrP knockout allele. We might mention at this point that we had considerable doubts as to whether a homozygous PrP knockout mouse would be healthy or even viable, in view of the fact that the PrP gene was singular, present in all vertebrates examined, expressed already during embryonal development in almost all tissues and mainly in the brain, which, as Woody Allen commented, is after all our second most important organ. It was therefore an exhilarating surprise when perfectly normal, homozygous PrP knockout offspring emerged from the matings. At that time we knew of only one widely conserved protein in vertebrates that could be absent without causing a deleterious phenotype, namely albumin, deleted as a consequence of natural mutations in both rats and humans. Our finding was so surprising at the time that a photograph of the PrP knockout mice made the cover of the Nature issue containing our report (B0eler et al., 1992) . Subsequently, discrete changes in electrophysiological properties (Collinge et al., 1994) and response to oxidative stress of cultured cells from knockout mice have been described (Brown et al., 2002) , albeit without revealing the function of PrP c at the molecular level.
As an aside, we should mention that a few years later, in contradiction to our findings and to our irritation, a Japanese group reported that their PrP knockout mice developed ataxia and cerebellar Purkinje cell loss as they aged (Sakaguchi et al., 1996) and that the phenotype could be abrogated by introduction of PrP transgenes. This discrepancy (Weissmann, 1996) was finally resolved by David Westaway and his colleagues (Moore et al., 1999) . They showed that the pathological phenotype of these mice was due to the extensive deletion introduced into their PrP genes, which unleashed a series of complex events resulting in the accumulation of doppel, a protein normally absent from postnatal brain. Doppel proved to be toxic for cerebellar neurons and, surprisingly, its effects were counteracted by PrP (Moore et al., 1999) . The lesson here is that knockouts can have unpredictable outcomes and that had the Japanese knockout been published first, it might well have been erroneously accepted that PrP is required for maintenance of cerebellar integrity (Weissmann and Aguzzi,
1999).
Intracerebral injection of our PrP knockout mice and their wild-type littermates with mouse-adapted scrapie prions was initiated as soon as sufficient mice were available. After some 6 months, all inoculated wild-type controls were dead of scrapie and, to our mounting excitement, mice devoid of PrP continued healthy week after week. Thirteen months after inoculation and following histopathological evaluation (carried out blind by Adriano Aguzzi), we felt safe in concluding that PrP knockout mice were completely resistant to disease. Equally important, after many bioassays, we concluded that there was no replication of prions (B0eler et al., 1993; Sailer et al., 1994) . Rarely, an inoculated mouse showed very low levels of infectivity, as subsequently also reported by others; this is generally attributed to residual inoculum, but it sewed as a trickle of water on the mills of the "protein only" antagonists (Chesebro and Caughey, 1993) . Susceptibility to disease and ability to replicate prions were restored by the introduction of PrP transgenes and, in fact, even enhanced if PrP was overexpressed (B0eler et al., 1993) .
These experiments, showing that PrP was essential for prion propagation and pathogenesis, fulfilled a central prediction of the "protein only" hypothesis and significantly promoted its acceptance, although they by no means constituted proof. The virus-friendly rear guard explained our results by proposing that PrP was a virus receptor, while the virinophiles welcomed PrP as the host-specified coat of the hypothetical nucleic acid.
As regards our current view of the structure of the infectious entity, it seems likely that a conformer of PrP c is an essential component; it is still not clear whether this is PrP sc, originally defined as a protease-resistant, aggregated form of PrP c (Meyer et al., 1986 ), or some other conformer, such as the somewhat oxymoronically designated "protease-sensitive PrP so' ' (Safar et al., 1998; Tzaban et al., 2002) . In vitro conversion of PrP c into a prpSc-like conformation, elicited by incubation with PrP s°, has been achieved; however, no increase in infectivity has been reported (Kocisko et al., 1994; Lucassen et al., 2003; Saborio et al., 2001) . Failure, to date, to convert PrP c into an infectious form in a cell-free system argues against a straightforward conformational change; rather, other components may be required, either in a structural or catalytic role. Whether the socalled "yeast prions" and the seeding mechanism underlying their replication provide a valid model for mammalian prions remains to be seen. The discovery of siRNAs and microRNAs, which would have escaped notice in previous analyses of prion preparations, both because of their size and their host origin, provides candidates for the hypothetical coprion and breathes a little life into the comatose "unified theory" mentioned above.
Whatever the implications for the nature of the prion, the generation of PrP knockout mice paved the way to reverse genetics of PrP and allowed the delineation of PrP sequences essential for prion susceptibility. The introduction of foreign PrP genes into knockout mice abrogated the species barrier for bovine BSE and human sCJD prions, allowing a practical bioassay. PrP knockout mice enabled the production of monoclonal antiPrP antibodies that could never be made in PrP-tolerant wild-type mice (Prusiner et al., 1993) . Tissue-specific expression of PrP in PrP knockout mice helped understand the spread of prions from the periphery to the CNS and their amplification in the lymphoreticular system.
The generation of healthy PrP knockout mice provided the first example of disease-resistant animals generated by genetic engineering and suggested that healthy PrP knockout cattle and sheep, resistant to BSE and scrapie, respectively, might be generated and prove useful as a source of pharmaceutical products; ongoing efforts, however, have not yet been successful. Last but not least, inhibition of PrP accumulation or its sequestration from the cell surface by antibodies or drugs might present an approach to therapy of prion disease in humans, albeit one fraught with difficulties. Sakaguchi, S., Katamine, S., Nishida, N., Moriuchi, R., Shigematsu, K., Sugimoto, T., Nakatani, A., Kataoka, Y., Houtani, T., Shirabe, S., et al. (1996) . Loss of cerebellar Purkinje cells in aged mice homozygous for a disrupted PrP gene. Nature 380, 528-531. Telling, G.C., Haga, T., Torchia, M., Tremblay, P., DeArmond, S.J., and Prusiner, S.B. (1996) . Interactions between wild-type and mutant prion proteins modulate neurodegeneration in transgenic mice.
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Note Added in Proof
As shown recently, the in vitro conversion of PrP ~ to PrP s~ is greatly accelerated by the addition of certain kinds of RNA (Adler et al., 2003; Deleault et al., 2003) . It is not yet known whether the RNA acts only as a catalyst or whether it also is incorporated into the conversion product, nor has it been reported whether the net production of conversion product is accompanied by an increase of infectivity. Adler, V., Zeiler, B., Kryukov, V,, Kascsak, R., Rubenstein, R., and Grossman A. (2003) . Small, highly structured RNAs participate in the conversion of human recombinant PrP(Sen) to PrP(Res) in vitro.
Introduction
The scrapie agent causes a degenerative neurological disease of sheep and goats. The agent is prototypic of a novel class of infectious pathogens called prions (Prusiner, 1982) . Both kuru and Creutzfeidt-Jakob disease (CJD) of humans (Gajdusek, 1977 ) also may be caused by pdons. With the development of an effective partial purification scheme, convincing evidence was obtained for a protein within the scrapie agent (Prusiner, 1982; Prusiner et al., 1980 Prusiner et al., , 1981 . The titer of the scrapie prion in partially purified fractions could be diminished both by proteolytic digestion (Prusiner et al., 1981) and by chemical modification with diethylpyrocarbonate (DEP) (McKinley et al., 1981 ) .
Having shown that the infectivity of the scrapie agent depended upon a protein or proteins, we began to search for proteins that were unique to purified fractions of the agent. Using fractions derived from an improved purification procedure, we identified a protein, designated PrP, of apparent molecular weight 27,000 to 30,000, which was found in all purified scrapie pdon fractions, but was absent from control preparations (Prusiner et al., 1982a; Bolton et al., 1982) . The native protein was resistant to hydrolysis catalyzed by proteases; however, denaturation by boiling in sodium dodecylsulfate (SDS) rendered PrP susceptible to enzymatic proteoiysis (Bolton et al., 1982) . PrP could be labeled with 14C-DEP; earlier studies have shown that DEP reversibly inactivates the infectious prion (Bolton et al., 1982; McKinley et al., 1981) .
On the basis of these observations, we asked whether PrP is a component of the prion or a pathologic product of infection. Evidence presented here indicates that PrP is a component of the prion. PrP is the first structural molecule within the scrapie agent to be identified. Our observations also demonstrate that the prion contains only one major protein, namely PrP. We do not know how many, if any, minor proteins the prion may contain.
Results
When sucrose gradient fractions enriched for the scrapie agent were radioiodinated, PrP was found to be a predominant protein (Bolton et al., 1982) . PrP was distinguished from normal brain proteins by its microheterogeneity (Mr 27,000-30,000) during SDS polyacrylamide gel electrophoresis and by its resistance to protease digestion in the native or nondenatured state. Figure 1 illustrates a comparison between purified scrapie and normal brain fractions after treatment with proteinase K. Though both samples originally contained similar amounts of protein, protease digestion under nondenaturing conditions hydrolyzed all proteins in the normal brain fraction, but left PrP intact in the scrapie fraction.
Although PrP has been found only in purified fractions from scrapie-infected brains, it is necessary to determine whether PrP is a structural component of the prion or a pathologic product of infection. Since denaturation of purified samples prior to SDS gel electrophoresis resulted in a significant loss of titer, we could not determine if PrP eluted from SDS polyacrylamide gels is sufficient for expression of prion infectivity. We approached this problem by asking whether the concentration of PrP is directly proportional to the titer of the infectious prion.
A relationship between PrP and scrapie infectivity was observed in discontinuous sucrose gradients used for obtaining our purified preparations of prions. To quantitate this relationship, the amount of radioiodinated PrP in gradient fractions was determined by scanning autoradiograms of electrophoretic gels with a laser densitometer. A correlation between the prion titer (IDs0 units/ml) and PrP concentration (units/ml) over nearly a 100-fold range was found in fractions I through 5 from the bottom of a sucrose gradient (Figure 2A ). To verify this relationship between infectivity and PrP, aliquots of fractions from three other preparative sucrose gradients were radioiodinated and held at 37°C for 30 min either with or without 100 p~g/ml of proteinase K. The aliquots were then electrophoresed into SDS polyacrylamide gels. The correlation between prion infectivity and PrP was confirmed in both undigested ( Figure 213 ) and protease-digested samples ( Figure 2C ). Although the results from these three gradients show a greater scatter of the data than was observed in the initial study, the same relationship between titer and protein concentration appears to hold.
